Serendipity, invention and innovation at X-VAX Reading time: 4 minutes [...]
About ArneThis author has not yet filled in any details.
So far Arne has created 9 blog entries.
X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program
X-Vax Technology Raises $56 Million in Upsized Series A Financing [...]
Petro C et al., HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates, JCI Insight. 2016;1(12).
Bolland S, Pierce SK, Ups and downs in the search for a herpes simplex virus vaccine, eLife. 2015;4.
Petro C et al., Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease, eLife. 2015;4.
Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease